Australia  

AstraZeneca to make billion COVID vaccine doses if tests succeed

Video Credit: Reuters Studio - Duration: 01:20s - Published
AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial.

Ciara Lee reports

0
shares
ShareTweetSavePostSend
 

A billion doses of a possible COVID-19 vaccine, to be available this year and next.

That's AstraZeneca's plan if tests are successful.

The pharmaceutical company on Thursday (May 21) added that it should shortly get results of an early stage clinical trial.

The British drugmaker has already signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

It's said that if results from the early stage tests are positive, they will lead to late stage trials in several countries.

Only a handful of vaccines in development have advanced to human trials.

That stage is seen as an indicator of safety and efficacy.

But it's the point when many new drugs fail.

Governments, drugmakers and researchers around the world are working on around 100 programs. Though experts warn it could take 12 to 18 months to develop a vaccine.

AstraZeneca also said it had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority towards the potential treatment.

Other drugmakers including Pfizer, Johnson & Johnson and Sanofi are also in various stages of vaccine development.

AstraZeneca said it was engaging with international bodies over the fair allocation and distribution of any new product around the world.




💡 One News Page Knowledge: Other News Mentions

AstraZeneca AstraZeneca British-Swedish pharmaceutical company

Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio    Duration: 01:13Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

COVID-19: Madurai Police uses drones with speakers to create awareness among people [Video]

COVID-19: Madurai Police uses drones with speakers to create awareness among people

Amid COVID-19 increasing cases in the country, police is taking different steps to aware people. Madurai Police is creating awareness among the people regarding COVID-19, with the help of three drones with speakers from which announcements are being made. Tamil Nadu has recorded over 48199 active cases with over 2030 deaths due to COVID-19 till yet.

Credit: ANI    Duration: 01:26Published
Masks, camera, action! Film crews slowly restart [Video]

Masks, camera, action! Film crews slowly restart

Film crews are tentatively resuming production in California with state-designated safety protocols in place. Lisa Bernhard produced this report.

Credit: Reuters - Politics    Duration: 01:48Published
World hunger rising and COVID-19 threatens to make it worse, says UN [Video]

World hunger rising and COVID-19 threatens to make it worse, says UN

It's put a UN deadline to eradicate hunger by 2030 in severe doubt. View on euronews

Credit: euronews (in English)    Duration: 01:40Published
Scindia targets Kamal Nath over COVID-19, praises CM Chouhan for his work [Video]

Scindia targets Kamal Nath over COVID-19, praises CM Chouhan for his work

Madhya Pradesh Chief Minister Shivraj Singh Chouhan along with Jyotiraditya Scindia attended the foundation stone laying ceremony and launch of grains market in Agar Malwa on July 14. During the event, Jyotiraditya Scindia targeted Congress leader and former CM of MP, Kamal Nath. He said, "When Kamal Nath was the CM, he didn't have time to hold a meeting over COVID-19 but he had the time to go to Indore for IIFA awards. A fighter came to the front and took the reins in his hands on March 23 and single handedly faced the pandemic in the state." He also took a pot shot on current political situation in Rajasthan.

Credit: ANI    Duration: 02:03Published

Oxford University Police Oxford University Police

Malala Yousafzai Graduates Oxford University [Video]

Malala Yousafzai Graduates Oxford University

CNN reports that Malala Yousafzai, has graduated from Oxford University. She and her family celebrated, with cake and confetti. Malala, is a 22-year-old Nobel Peace Prize winner, who lived after being shot in the head at 15 by the Taliban. Born in Pakistan, Malala is an activist who speaks out about girls education and human rights. On Friday Malala tweeted, "Hard to express my joy and gratitude right now as I completed my Philosophy, Politics and Economics degree at Oxford.

Credit: Wochit News    Duration: 00:41Published
British protesters target symbols of slavery and empire [Video]

British protesters target symbols of slavery and empire

Protesters in Oxford demanded the removal of a statue of colonialist Cecil Rhodes, while in London, a slave-trader's statue was targeted as part of protests against symbols of the slave trade and empire.

Credit: Reuters Studio    Duration: 02:01Published

Biomedical Advanced Research and Development Authority Biomedical Advanced Research and Development Authority Government organization in Washington D.C., United States


Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson Cease Production Of Lightening Products [Video]

Johnson & Johnson Cease Production Of Lightening Products

The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.

Credit: Wochit News    Duration: 00:33Published
Band-Aid to Make Black and Brown Flesh-Tone Bandages [Video]

Band-Aid to Make Black and Brown Flesh-Tone Bandages

The Johnson & Johnson-owned company plans to create a range of bandages to "embrace the beauty of diverse skin"

Credit: Cover Video STUDIO    Duration: 00:50Published
Johnson & Johnson Speeds Up Vaccine Timeline [Video]

Johnson & Johnson Speeds Up Vaccine Timeline

Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.

Credit: Wochit News    Duration: 00:35Published
Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine [Video]

Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine

The early-stage human trial will begin in the second half of July as opposed to its initial forecast of September.

Credit: Cover Video STUDIO    Duration: 00:56Published
Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1) [Video]

Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1)

Johnson & Johnson is the world's largest health care company. Business Insider reports that the company plans to start testing its coronavirus vaccine candidate in humans in July. On Wednesday, Johnson & Johnson it will move up the timeline by about two months to start clinical trials. It was previously aiming for trials in September. 1,045 healthy volunteers in the US and Belgium will join the study, which starts in July.

Credit: Wochit News    Duration: 00:34Published

Sanofi Sanofi French pharmaceutical company

Sanofi invests €610 million in French vaccine research and production [Video]

Sanofi invests €610 million in French vaccine research and production

Sanofi invests €610 million in French vaccine research and production

Credit: Euronews English    Duration: 02:09Published

Pfizer Pfizer American multinational pharmaceutical corporation

Pfizer, BioNTech get vaccine 'fast track' from FDA [Video]

Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process. Jillian Kitchener has more.

Credit: Reuters - Politics    Duration: 01:02Published
Stocks rise on recovery hopes [Video]

Stocks rise on recovery hopes

U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:22Published

You Might Like


Tweets about this

rubengarciaes

Ruben Garcia COVID-19: British drugmaker AstraZeneca aiming to make 2 billion doses of vaccine starting this September – CEO Eas… https://t.co/UFSJl7mDB3 3 days ago

chaselionsway

nobody RT @Sgmrpharma: AstraZeneca to make billion COVID vaccine doses if tests succeed The first agreements have been signed to supply at least… 1 week ago

Sgmrpharma

SGMR Pharmaceuticals Pvt. Ltd. AstraZeneca to make billion COVID vaccine doses if tests succeed The first agreements have been signed to supply a… https://t.co/xWNN9ZwnVt 1 week ago

WendyMc41783380

Wozel123 RT @CV2175911874: 2 Billion doses by September of what, something that has not been tested properly, totally been rushed through and might… 1 week ago

CV2175911874

Unknown_Traveler 2 Billion doses by September of what, something that has not been tested properly, totally been rushed through and… https://t.co/7XqXhnygtB 1 week ago


Related videos from verified sources

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021 [Video]

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021

At $1.6 billion, Novavax receives the largest amount the Trump administration has awarded to a company to manufacture millions of doses of a coronavirus vaccine set to be delivered by January...

Credit: Veuer     Duration: 01:20Published
WHO aims to deliver 2B vaccine doses by the end of 2021 [Video]

WHO aims to deliver 2B vaccine doses by the end of 2021

The World Health Organization is working to deliver 2 billion doses of COVID-19 vaccines by the end of 2021. The organization announced the new goal was set this morning. About half of the doses are..

Credit: KTNV Channel 13 Las Vegas     Duration: 00:38Published